Hinge Health, Inc. HNGE
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 52.37% | 53.00% | 47.23% | 45.60% | 54.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 52.37% | 53.00% | 47.23% | 45.60% | 54.85% |
| Cost of Revenue | 8.77% | -28.73% | 18.55% | 25.43% | 74.26% |
| Gross Profit | 62.03% | 86.50% | 53.98% | 50.04% | 48.09% |
| SG&A Expenses | 16.10% | -72.53% | 43.29% | 59.10% | 572.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 235.00% | -94.96% | -- | -- | -- |
| Total Operating Expenses | 15.13% | -76.05% | 35.73% | 48.91% | 570.33% |
| Operating Income | 927.26% | 106.96% | 144.11% | 30.35% | -3,208.48% |
| Income Before Tax | 3,379.43% | 107.71% | 98.17% | 23.13% | -4,483.98% |
| Income Tax Expenses | -1,886.89% | 326.99% | -18.44% | 112.83% | -190.30% |
| Earnings from Continuing Operations | 3,212.69% | 107.59% | 104.96% | 18.36% | -4,353.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3,212.69% | 107.59% | 104.96% | 18.36% | -4,353.43% |
| EBIT | 927.26% | 106.96% | 144.11% | 30.35% | -3,208.48% |
| EBITDA | 1,037.35% | 107.05% | 138.58% | 29.35% | -3,313.12% |
| EPS Basic | 3,133.33% | 104.17% | -94.53% | -79.61% | -1,271.38% |
| Normalized Basic EPS | 3,298.46% | 104.29% | -61.36% | -78.79% | -1,311.59% |
| EPS Diluted | 2,920.51% | 103.97% | -68.44% | -80.82% | -1,271.38% |
| Normalized Diluted EPS | 3,089.23% | 104.06% | 123.08% | -80.05% | -1,311.59% |
| Average Basic Shares Outstanding | 2.55% | 79.76% | 412.78% | 480.61% | 224.74% |
| Average Diluted Shares Outstanding | 9.72% | 89.90% | -11.16% | 517.21% | 224.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |